Texas House Bill HB1362

Texas 2009 - 81st Regular

• Out of House Committee: 4/22/09
• Voted on by House: 5/4/09
• Out of Senate Committee: 5/14/09
• Voted on by Senate: 5/21/09
• Governor Action: 6/19/09
• Enrolled: 5/26/09
• Passed: 6/19/09

Caption

Relating to the pilot program for reporting of methicillin-resistant Staphylococcus aureus infections.

Impact

The implementation of this bill is expected to improve the tracking of MRSA infections across Texas. By requiring local health authorities to oversee and administer the program, it aims to create a more detailed understanding of the prevalence of MRSA in communities. The data collected will contribute to evaluating the public health impact of MRSA in the state, potentially leading to better response strategies and health policies based on the reported cases. Additionally, the program shall facilitate the public dissemination of information regarding MRSA to raise awareness about this serious health issue.

Summary

House Bill 1362 seeks to establish a structured program for the reporting of methicillin-resistant Staphylococcus aureus (MRSA) infections in Texas. The bill amends Section 81.0445 of the Health and Safety Code to create a program that mandates clinical laboratories to report all positive MRSA cases to local health authorities. This reporting is to be carried out through automated and secure electronic data transmission, aiming to enhance public health data collection and management related to this specific infection.

Contention

Noteworthy points of contention surrounding HB 1362 include possible concerns regarding the resources required from local health authorities to effectively implement the reporting program. Opponents may argue about the burden placed on smaller health departments, which might lack the infrastructure to handle additional reporting processes. Furthermore, the pilot nature of the program as outlined in the bill suggests that results and feasibility assessments will be critical in determining the program's permanence and efficacy in tackling MRSA infections in Texas.